From theheart.org on Medscape

Coverage from the

American Heart Association (AHA) Scientific Sessions 2023

November 11 - 13, 2023; Philadelphia, Pennsylvania

November 11 - 13, 2023 Philadelphia, Pennsylvania

AHA 2023 In MI With Anemia, Results May Favor Liberal Transfusion Although the primary outcome was not statistically different between a liberal and more restrictive transfusion strategy, secondary results suggest some advantages for the liberal approach.
Medscape Medical News, November 11, 2023
AHA 2023 Semaglutide 'A New Pathway' to CVD Risk Reduction: SELECT The weight loss drug showed a consistent reduction in major cardiovascular events over a 3-year follow up in patients with a history of heart disease who were overweight or obese.
Medscape Medical News, November 11, 2023

Conference News

AI-Aided Stethoscope Beats PCP in Detecting Valvular HD
Medscape Medical News, December 13, 2023
AHA 2023 New PCSK9 Inhibitor Allows 3-Month Treatment Intervals
MDedge News, November 29, 2023
AHA 2023 AI Interpretation of CCTA: Inflammation as CV Risk Factor
MDedge News, November 27, 2023
AHA 2023 Cardiologists, Patients Can Talk Drug Costs
MDedge News, November 27, 2023
AHA 2023 Sudden Cardiac Deaths Down Among NCAA Athletes
Medscape Medical News, November 27, 2023
AHA 2023 AI Voice Analysis App May Detect Worsening HF Early
Medscape Medical News, November 22, 2023
AHA 2023 Promising First Results With DNA Editing to Lower LDL
MDedge News, November 21, 2023
AHA 2023 'Smart' Stethoscope Spots Peripartum Cardiomyopathy
Medscape Medical News, November 21, 2023
AHA 2023 Alternative Antirejection Regimen in Pediatric Heart Transplant
MDedge News, November 21, 2023
AHA 2023 Single Injection Reduces Blood Pressure for 6 Months
Medscape Medical News, November 20, 2023
AHA 2023 AI-ECG Gets STEMI Patients to Cath Lab Sooner
MDedge News, November 16, 2023
AHA 2023 More Evidence of Better Outcomes With 120 mm Hg BP Target
Medscape Medical News, November 16, 2023
AHA 2023 Pharmacist-Based Strategy Places More Patients on Statins
MDedge News, November 16, 2023
AHA 2023 Low-Salt Diet Cut BP by 6 mm Hg in 1 Week: CARDIA-SSBP
Medscape Medical News, November 15, 2023

AHA 2023 Dual Energy Conversion Safe, Reliable for AF With Obesity
MDedge News, November 14, 2023
AHA 2023 Impressive Bleeding Profile With Factor XI Inhibitor in AF
Medscape Medical News, November 13, 2023
AHA 2023 Better Postpartum BP Control With Self-Monitoring: POP-HT
Medscape Medical News, November 12, 2023
AHA 2023 Sustained Reductions in Lp(a) Achieved With Novel siRNA Drug
MDedge News, November 12, 2023
AHA 2023 Dropping Aspirin Cuts Bleeding in LVAD Patients
MDedge News, November 12, 2023
AHA 2023 Blood Pressure Lowering Reduces Dementia Risk
Medscape Medical News, November 12, 2023
AHA 2023 Apixaban Cuts Stroke but Ups Bleeding in Subclinical AF
Medscape Medical News, November 12, 2023
AHA 2023 Potential Dapagliflozin Benefit Post-MI Is Not a 'Mandate'
MDedge News, November 11, 2023
AHA 2023 In MI With Anemia, Results May Favor Liberal Transfusion
Medscape Medical News, November 11, 2023
AHA 2023 Angioplasty Finally Proven Beneficial in Stable Angina
MDedge News, November 11, 2023
AHA 2023 Semaglutide 'A New Pathway' to CVD Risk Reduction: SELECT
Medscape Medical News, November 11, 2023
AHA 2023 Women Have Worse Outcomes in Cardiogenic Shock
Medscape Medical News, November 9, 2023
AHA 2023 Marijuana Use Tied to Heart Failure, MI, Stroke
Medscape Medical News, November 9, 2023
AHA 2023 Novel Leadless Pacemaker Prototype Partly Recharges Itself
Medscape Medical News, November 6, 2023

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

The Ethics of Sham PCI and the Clinical Relevance of ORBITA-2
John M. Mandrola, MD; Rasha Al-Lamee, MBBS, MA, PhD; Christopher A. Rajkumar, MBBS, PhD
Is Lifelong LDL-C Lowering Within Reach?
Michelle L. O'Donoghue, MD, MPH; Sekar Kathiresan, MD
Key Updates in Obesity From AHA 2023
Javed Butler, MD
Predicting HF Worsening: Speech Analysis Beats Weighing Scales
Ileana L. Piña, MD, MPH; William T. Abraham, MD
Key Updates in Diabetes From AHA 2023
Javed Butler, MD
To Anticoagulate or Not in Subclinical AF: ARTESiA
John M. Mandrola, MD; Jeff S. Healey, MD, MSc
ARTESIA Doesn't Answer a Common Question in Cardiology
John M. Mandrola, MD
PCI, the Antianginal 'Pill': ORBITA-2 in Detail
Michelle L. O'Donoghue, MD, MPH; Rasha Al-Lamee, MBBS, MA, PhD; Christopher A. Rajkumar, MBBS, PhD
Is It Time for Cardiologists to Treat Obesity?
Michelle L. O'Donoghue, MD, MPH; Nicholas A. Marston, MD, MPH
ORBITA-2 Saves Interventional Cardiology, Questions Guidance
John M. Mandrola, MD
Positive Results From SELECT Begins a New Era in Cardiology
John M. Mandrola, MD
Mandrola's Top Trials to Look for at AHA 2023
John M. Mandrola, MD

Popular News From AHA 2022

Olpasiran Provides Large Sustained Cut in Lp(a): OCEAN(a)-DOSE The small interfering RNA product showed reductions of more than 95% in levels of Lp(a) at doses of 75 mg or more when given every 12 weeks in a new phase 2 study.
Medscape Medical News, Nov 07, 2022
IRONMAN Galvanizes Case for IV Iron Repletion in Heart Failure The trial missed its primary endpoint, but makes unique contributions; many see it as further evidence that the treatment helps iron-deficient patients with heart failure.
Medscape Medical News, Nov 14, 2022
Four-Drug Combo Gets BP Down in One Step: QUARTET-USA Use of a combination product containing quarter doses of four different drugs reduced blood pressure by almost 5 mm Hg more than a standard dose of one antihypertensive agent.
Medscape Medical News, Nov 08, 2022

Previous Coverage

Related Resources